The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle

References

• Alberts D. S., Peng Y. M., Chen G., Moon T. E., Cetas T. C., Heschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse model. Journal of the National Cancer Institute 1980; 65: 455–460
   PubMed Web of Science ®Google Scholar
• Blake W. D. Some effects of pentobarbital and anesthesia on renal hemodynamics, water and electrolyte excretion in the dog. American Journal of Physiology 1957; 191: 393–398
   PubMedGoogle Scholar
• Veterinary Pharmacology and Therapeutics 5th edn, N. H. Booth, L. E. McDonald, 1982; 175–345
   Google Scholar
• Buhring M., Eggana P. Renal function in hyperthermia. Hyperthermia in Cancer Treatment, L. J. Anghileri, J. Robert. CRC Press, Boca Raton, Florida 1986; vol. III: 170–182
   Google Scholar
• Bull J. M. C. An update on the anti-cancer effects of a combination of chemotherapy and hyperthermia. Cancer Research 1984; 44: 4853s–4856s, (suppl.)
   PubMed Web of Science ®Google Scholar
• Cronau L. H., Bourke D. L., Bull J. M. General anesthesia for whole body hyperthermia. Cancer Research 1984; 44: 4873s–4877s, (suppl.)
   Google Scholar
• Cvitkovic E., Spoulding J., Bethune V., Martin J., Withmore W. F. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 1977; 39: 1357–1361
   PubMed Web of Science ®Google Scholar
• Denekamp J., Terry N. H. A., Sheldon P. W., Chu A. M. The effect of pentobarbital anaesthesia on the radiosensitivity of four mouse tumours. International Journal of Radiation Biology 1979; 35: 277–280
   Web of Science ®Google Scholar
• Douple E. B., Strohbein J. W., De Sieyes D. C., Alborough D. P., Trembly B. S. Therapeutic potentiation of cis-dichlorodiammineplatinum (n) and radiation by interstitial microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph 1982; 61: 259–262
   Google Scholar
• Earhart R. H., Martin P. A., Tutsch K. D., Erturk E., Wheeler R. H., Bull F. E. Improvement in the therapeutic Index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat. Cancer Research 1983; 43: 1187–1194
   PubMed Web of Science ®Google Scholar
• Gerard H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmocokinetics in three patients treated with cis-diamminnechloroplatinum (II) and whole-body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
   PubMedGoogle Scholar
• Herman T. S., Zukoski C. F., Anderson R. M., Hutter J. J., Blitt C. D., Malone J. M., Larson D. F., Dean J. C., Roth H. B. Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies. Cancer Treatment Reports 1982; 66: 259–265
   PubMedGoogle Scholar
• Hornsey S., Myers R., Andreozzi U. Differences in the effects of anesthesia on hypoxia in normal tissues. International Journal of Radiation Biology 1977; 32: 609–612
   Web of Science ®Google Scholar
• Jirtle R., Clifton K. H., Rankin J. H. G. Measurement of mammary tumor blood flow in unanesthetized rats. Journal of the National Cancer Institute 1978; 60: 881–886
   PubMedGoogle Scholar
• Keizer H. J., Van Putten L. M. The radioprotective action on bone marrow CFU during immobilization of mice. Radiation Research 1976; 66: 326–336
   PubMed Web of Science ®Google Scholar
• Kociba R. J., Sleight S. D. Acute toxicologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat. Cancer Chemotherapy Reports 1971; 55: 1–8
   PubMedGoogle Scholar
• Krakoff I. H. Nephrotoxicity of cis-dichlorodiammineplatinum (II). Cancer Treatment Reports 1979; 63: 1523–1525
   PubMedGoogle Scholar
• LeRoy A. F., Lutz R. J., Dedrick R. L., Litterst C. L., Guarino A. M. Pharmacokinetic study of cis-dichlorodiammineplatinum (II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic milieu. Cancer Treatment Reports 1979; 63: 59–71
   PubMedGoogle Scholar
• Litterst C. L. Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration. Toxicology and Applied Pharmacology 1981; 61: 99–108
   PubMed Web of Science ®Google Scholar
• Lumb W. V., Jones E. W. Veterinary Anesthesia. Lea and Febiger, Philadelphia 1984
   Google Scholar
• Mansfield B. The effect of anesthetic agents on acute cisplatin-mediated nephrotoxicity in Fischer 344 rats. Texas Woman's University, Houston, Texas 1987, Masters thesis
   Google Scholar
• Mella O. Combined hyperthermia and cis-diamminedichloroplatinurn in BD IX rats with transplanted DT4A tumours. International Journal of Hyperthermia 1985; 1: 171–183
   PubMedGoogle Scholar
• Mella O., Dahl O. Timing of combined hyperthermia and 1 3 (2-chloroethyl)-l-Nitrosourea or cis-diamrninedichloroplatinum in BD IX rats with BT4A tumours. Anticancer Research 1985; 5: 259–264
   PubMed Web of Science ®Google Scholar
• Mella O., Erikson R., Laeriem O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. European Journal of Cancer and Clinical Oncology 1987; 23: 365–373
   PubMedGoogle Scholar
• Pretorius R. G., Petrilli E. S., Kean C., Ford L. C., Hoeschele J. D., Lagasse L. P. Comparison of the I.V. and LP. routes of administration of cisplatin in dogs. Cancer Treatment Reports 1981; 65: 1055–1062
   PubMedGoogle Scholar
• Riviere J. E., Page R. L., Dewhirst M. W., Tyczkowska K., Thrall D. E. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. International Journal of Hyperthermia 1986; 2: 351–358
   PubMedGoogle Scholar
• Rosenberg B., Van Camp L., Troska J. E., Mansour V. H. Platinum compounds: a new class of potent anti-tumor agents. Nature 1969; 222: 385–386
   PubMed Web of Science ®Google Scholar
• Sheldon P. W., Chu A. M. The effects of anesthetics on the radiosensitivity of a murine tumor. Radiation Research 1979; 79: 568–578
   PubMedGoogle Scholar
• Sheldon P. W., Hill S. A., Moulder J. E. Radioprotection by pentobarbitone sodium of a murine tumor in vivo. International Journal of Radiation Biology 1977; 6: 571–575
   Google Scholar
• Siddik Z. H., Newell D. R., Boxal F. E., Harrap K. R. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochemical Pharmacology 1987; 36: 1925–1932
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. Effect of cis-diamminedichloroplatinum (II) combined with whole body hyperthermia on renal injury. Cancer Research 1988; 48: 440–446
   PubMed Web of Science ®Google Scholar
• Wondergem J., Haveman J., Van der Schueren E., Van den Hoeven H., Breur K. The influence of misonidazole on the radiation response of murine tumors of different size: possible artifacts caused by pentobarbital anesthesia, International Journal of Radiation Oncology. Biology and Physics 1981; 7: 755–760
   Google Scholar
• Zanelli G. D., Lucas P. B., Fowler J. F. The effect of anaesthetics on blood perfusion in transplanted mouse tumours. British Journal of Cancer 1975; 32: 380–390
   PubMed Web of Science ®Google Scholar